Zymogenetics Inc Sample Contracts

LEASE
Lease • March 28th, 2003 • Zymogenetics Inc • Biological products, (no disgnostic substances) • Washington
AutoNDA by SimpleDocs
CONTENTS
Shareholders' Agreement • September 10th, 2001 • Zymogenetics Inc • Washington
ZYMOGENETICS, INC. (a Washington corporation) 14,000,000 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • January 7th, 2010 • Zymogenetics Inc • Biological products, (no disgnostic substances) • New York

ZymoGenetics, Inc., a Washington corporation (the “Company”), confirms its agreement with Leerink Swann LLC (“Leerink Swann”) and each of the other Underwriters named in Schedule A hereto (collectively, the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), for whom Leerink Swann is acting as representative (in such capacity, the “Representative”), with respect to (i) the issue and sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of the respective numbers of shares of Common Stock, no par value, of the Company (“Common Stock”) set forth in said Schedule A, and (ii) the grant by the Company to the Underwriters, severally and not jointly, of the option described in Section 2(b) hereof to purchase all or any part of 2,100,000 additional shares of Common Stock to cover overallotments, if any. The aforesaid 14,000,000 shares of Common Stock (the “Initial Securities”) to be purcha

EXHIBIT 10.7 ZYMOGENETICS, INC. SERIES B PREFERRED STOCK PURCHASE AGREEMENT October 20, 2000 TABLE OF CONTENTS
Preferred Stock Purchase Agreement • September 10th, 2001 • Zymogenetics Inc • Washington
EXHIBIT 10.10 ZYMOGENETICS, INC. INVESTORS' RIGHTS AGREEMENT TABLE OF CONTENTS
Rights Agreement • September 10th, 2001 • Zymogenetics Inc • Washington
RECITALS
Pledge and Security Agreement • November 2nd, 2001 • Zymogenetics Inc • Biological products, (no disgnostic substances)
WITNESSETH:
License Agreement • January 10th, 2002 • Zymogenetics Inc • Biological products, (no disgnostic substances)
EXHIBIT 9.1 VOTING AGREEMENT
Voting Agreement • September 10th, 2001 • Zymogenetics Inc • Washington
Exhibit 10.8 EMPLOYMENT AGREEMENT
Employment Agreement • March 28th, 2002 • Zymogenetics Inc • Biological products, (no disgnostic substances) • Washington
EXHIBIT 10.35 EMPLOYMENT AGREEMENT
Employment Agreement • January 10th, 2002 • Zymogenetics Inc • Biological products, (no disgnostic substances) • Washington
PROMISSORY NOTE
Zymogenetics Inc • November 2nd, 2001 • Biological products, (no disgnostic substances) • Washington
EXHIBIT 10.28 COLLABORATIVE DEVELOPMENT AND MARKETING AGREEMENT by and between ZymoGenetics, Inc.
Development and Marketing Agreement • November 2nd, 2001 • Zymogenetics Inc • Biological products, (no disgnostic substances) • New York
W I T N E S S E T H
Agreement and Waiver • September 10th, 2001 • Zymogenetics Inc • Washington
AutoNDA by SimpleDocs
AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreement • March 1st, 2010 • Zymogenetics Inc • Biological products, (no disgnostic substances) • Washington

This AGREEMENT, dated as of July 3, 2008 (the “Effective Date”), is between ZymoGenetics, Inc., a Washington corporation (as supplemented by Section 13, the “Company”), and Darren R. Hamby (“Executive”).

AMENDED AND RESTATED EMPLOYMENT AGREEMENT
Employment Agreement • August 1st, 2007 • Zymogenetics Inc • Biological products, (no disgnostic substances) • Washington

This AGREEMENT, effective April 30, 2001, is between ZymoGenetics, Inc., a Washington corporation (“Company”) and James A. Johnson (“Executive”).

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • August 5th, 2008 • Zymogenetics Inc • Biological products, (no disgnostic substances) • New York

REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 26, 2008, by and between ZYMOGENETICS, INC., a Washington corporation (the “Company”), and Deerfield Private Design Fund, L.P. (“Deerfield Private Design”) and Deerfield Private Design International, L.P. (“Deerfield Private Design International” and together with Deerfield Private Design, the “Buyer”).

AGREEMENT AND PLAN OF MERGER BY AND AMONG BRISTOL-MYERS SQUIBB COMPANY, ZEUS ACQUISITION CORPORATION AND ZYMOGENETICS, INC. Dated as of September 7, 2010
Agreement and Plan of Merger • September 9th, 2010 • Zymogenetics Inc • Biological products, (no disgnostic substances) • Delaware
EXCLUSIVE PATENT LICENSE AGREEMENT between AVENTIS BEHRING GMBH AND ZYMOGENETICS, INC.
License Agreement • March 28th, 2003 • Zymogenetics Inc • Biological products, (no disgnostic substances) • Delaware
ZYMOGENETICS, INC. (a Washington corporation) 6,000,000 Shares of Common Stock PURCHASE AGREEMENT
Purchase Agreement • October 15th, 2003 • Zymogenetics Inc • Biological products, (no disgnostic substances) • New York
FIRST AMENDED AND RESTATED STRATEGIC ALLIANCE AGREEMENT by and between ZymoGenetics, Inc. and Serono Technologies S.A. Amended and Restated as of: August 28, 2008 “[ * ]” = omitted, confidential material, which material has been separately filed with...
Strategic Alliance Agreement • November 5th, 2008 • Zymogenetics Inc • Biological products, (no disgnostic substances) • New York

This First Amended and Restated Strategic Alliance Agreement is made as of the Effective Date, by and between ZymoGenetics, Inc., a Washington corporation (“ZGEN”), and Serono Technologies S.A., a Swiss corporation (“Merck Serono”).

ZYMOGENETICS, INC. (a Washington corporation) 7,500,000 Shares of Common Stock PURCHASE AGREEMENT
Purchase Agreement • August 4th, 2005 • Zymogenetics Inc • Biological products, (no disgnostic substances) • New York
THIRD RESTATED LICENSE AGREEMENT FOR IL-21 EMBODIMENTS by and between ZymoGenetics, Inc., and Novo Nordisk A/S Effective Date: December 3, 2009
License Agreement • March 1st, 2010 • Zymogenetics Inc • Biological products, (no disgnostic substances) • New York

This Third Restated License Agreement for IL-21 Embodiments (as defined herein) (“Agreement”) is entered into as of December 3, 2009 (“Effective Date”) by and between ZymoGenetics, Inc., a Washington corporation (“ZGEN”), and Novo Nordisk A/S, a Danish corporation (“NN”).

Time is Money Join Law Insider Premium to draft better contracts faster.